Emerging Trends in Artificial Blood

摘要: Blood substitutes are currently undergoing preliminary clinical trials to determine their safety. Two distinctly different classes of oxygen carriers being developed, each capable transporting and delivering peripheral tissues. The delivery by these two methodologies may have both benefits risks which unique its class. Early been promising. However, effective use blood involve using them in conjunction with other techniques such as normovolemic hemodilution effectively reduce or eliminate the need for transfusions certain instances. this first generation clinically safe will not replace allogeneic a means treating many types anemia.